$12.05
-0.84 (-6.52%)
Open$12.73
Previous Close$12.89
Day High$12.73
Day Low$11.61
52W High$55.89
52W Low$5.20
Volume—
Avg Volume105.0K
Market Cap146.82M
P/E Ratio—
EPS$-11.67
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
-66.5% upside
Current
$12.05
$12.05
Target
$4.04
$4.04
$2.50
$4.04 avg
$4.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.29M | 10.78M | 16.40M |
| Net Income | -152,068,374 | -178,019,688 | -3,544,265 |
| Profit Margin | -1,834.5% | -1,742.8% | -21.6% |
| EBITDA | -145,691,069 | -180,029,286 | -3,398,004 |
| Free Cash Flow | — | — | -3,167,900 |
| Rev Growth | -23.1% | -23.1% | +19.8% |
| Debt/Equity | — | — | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |